Zika Virus on a Spreading Spree: what we now know that was unknown in the 1950's

Rupsa Basu1, Ebenezer Tumban2

  • 1Department of Biological Sciences, Michigan Technological University, Houghton, MI, 49931, USA.

Virology Journal
|October 8, 2016
PubMed

Insights

Zika virus (ZIKV) outbreaks have surged globally since 2007, linked to severe neurological and congenital syndromes. Research faces challenges, including antibody-dependent enhancement of ZIKV infection.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Zika virus (ZIKV) is a mosquito-borne flavivirus previously causing mild infections.
  • Since 2007, ZIKV outbreaks have spread globally, associated with severe health issues.
  • Notable ZIKV-related conditions include Guillain-Barré syndrome and congenital abnormalities.

Purpose of the Study:

  • To review the ZIKV outbreak trajectory over the past decade.
  • To identify novel ZIKV transmission routes observed in recent epidemics.
  • To detail the characteristics of congenital Zika syndrome.

Main Methods:

  • Literature review of ZIKV outbreaks and transmission.
  • Analysis of clinical manifestations and epidemiological data.
  • Synthesis of current research challenges and findings.

Main Results:

  • ZIKV outbreaks have expanded significantly in geographic reach and impact.
  • Three novel transmission pathways have been identified.
  • Congenital Zika syndrome presents with specific neurological and developmental anomalies.
  • A concerning finding is that anti-dengue antibodies may enhance ZIKV infection.

Conclusions:

  • ZIKV poses a significant global health threat due to its expanding outbreaks and severe associated syndromes.
  • Understanding novel transmission modes is crucial for effective control strategies.
  • Further research is urgently needed, particularly regarding the role of pre-existing antibodies and the development of targeted interventions.